Literature DB >> 9890355

Cisplatin induced reversible bilateral vocal cord paralysis: an undescribed complication of cisplatin.

H Taha1, S Irfan, M Krishnamurthy.   

Abstract

BACKGROUND: Bilateral vocal cord paralysis is uncommon. Most cases occur secondary to trauma, malignancy, surgery, or intubation. Also, it was reported as a side effect of Vinca alkaloids.
METHODS: We report a patient with small cell lung cancer who developed bilateral vocal cord paralysis and needed to be intubated after treatment with cisplatin and etoposide. All workups excluded metastases as a cause of bilateral vocal cord paralysis. The patient required tracheostomy; she did not receive any further chemotherapy. After 11 weeks, vocal cord paralysis disappeared, tracheostomy was reversed, and the patient remained symptom free; however, 6 months later, the patient developed brain and liver metastases and died from her disease with no evidence of vocal cord paralysis.
RESULTS: We report a case of reversible bilateral vocal cord paralysis that we believe to be secondary to cisplatin toxicity, which is an undescribed complication of this drug.
CONCLUSION: Cisplatin can induce reversible bilateral vocal cord paralysis. The concurrent use of cisplatin and etoposide might have contributed to this complication in our patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890355     DOI: 10.1002/(sici)1097-0347(199901)21:1<78::aid-hed11>3.0.co;2-7

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Endo-extralaryngeal Laterofixation of the Vocal Folds in Patients with Bilateral Vocal Fold Immobility.

Authors:  Susanne Wiegand; Afshin Teymoortash; Holger Hanschmann
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

2.  An unusual cause of difficult weaning in a patient with newly diagnosed small cell lung cancer.

Authors:  G Deslypere; K Cuppens; K Pat; J Aumann; K Demuynck; L Spaas
Journal:  Respir Med Case Rep       Date:  2015-09-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.